NCT02867839 2024-12-03
RESCUE-GC
Peking University Cancer Hospital & Institute
Phase 3 Terminated
Clinical Trials
16 trialsNCT01285557 2024-09-19
DIGEST
Taiho Oncology, Inc.
Phase 3 Terminated
NCT02191566 2022-12-08
SOHUG
Kangbuk Samsung Hospital
Phase 2 Terminated
NCT04070313 2021-12-06
A Phase II Study of S-1 Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer in Taiwan
TTY Biopharm
Phase 2 Terminated
NCT03585062 2021-01-08
Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer
Zhejiang Provincial People's Hospital
Phase 2 Terminated
NCT02862535 2020-12-24
Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Anti-Cancer Agents in Japanese Participants With Gastric or Gastroesophageal Junction Adenocarcinoma
Gilead Sciences
Phase 1 Terminated
NCT00429858 2020-09-18
Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer
University of California, San Francisco
Phase 2 Terminated
NCT02216149 2018-08-28
FluoHeart
Helsinki University Central Hospital
Phase 2 Terminated
NCT01704690 2017-04-07
Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer
Peking University
Phase 2/3 Terminated
NCT01946061 2016-08-19
A Phase II Trial of Adjuvant Chemotherapy With S-1 Plus Oxaliplatin for Locally Advanced Gastric Cancer
Yonsei University
Phase 2 Terminated
NCT01980810 2016-06-14
GC-A-003
ChineseAMS
Phase 2 Terminated
NCT00602745 2016-05-26
S-1 Pancreas
Sanofi
Phase 3 Terminated
NCT01403259 2014-08-20
SOX as Salvage Treatment in Nasopharyngeal Carcinoma
Fudan University
Phase 2 Terminated
NCT01106066 2013-06-14
Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT
Samsung Medical Center
Phase 1/2 Terminated
NCT01096745 2011-06-23
Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer
Gyeongsang National University Hospital
Phase 2 Terminated
NCT00503321 2009-01-23
eNCIT-Japan
Eastern Network of Cancer Immunological Therapy, Japan
Phase 2/3 Terminated